# Jasper Therapeutics, Inc.: Form 8-K, filed Mar 11, 2022

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2022-03-11
- Accepted by EDGAR: Mar 11, 2022, 16:01 ET
- Period: 2022-03-07
- Accession: 0001213900-22-011854
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390022011854/ea156711-8k_jasperther.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390022011854/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390022011854/ea156711-8k_jasperther.htm

Filed Mar 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-011854. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.